Recursion Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Recursion Pharmaceuticals, Inc.‘s stocks are currently a part of 95 hedge funds’ portfolios, which represents 40.19% of the total amount of its stocks outstanding. This makes up a total of 70.54M shares of Recursion Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -42.97% or -53.15M shares fewer. As for the holding position changes, 38.95% (37) of current hedge fund investors increased the number of shares held, 17.89% (17) of current holders sold a part of the shares held, and 8.42% (8) closed the holdings completely. 12 hedge funds are new holders of Recursion Pharmaceuticals, Inc. stock in Q1 2023, it is 12.63% of total holders.
Hedge funds holding Recursion Pharmaceuticals (Q1 2019 – Q1 2023)
| Q1 2019 | 1 |
|---|---|
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 74 |
| Q3 2021 | 82 |
| Q4 2021 | 124 |
| Q1 2022 | 125 |
| Q2 2022 | 129 |
| Q3 2022 | 139 |
| Q4 2022 | 142 |
| Q1 2023 | 95 |
Hedge funds changes in Recursion Pharmaceuticals positions (Q1 2019 – Q1 2023)
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 0 | 0 | 0 | 0 | 1 |
| Q3 2020 | 0 | 0 | 0 | 0 | 1 |
| Q4 2020 | 0 | 0 | 0 | 0 | 1 |
| Q1 2021 | 0 | 0 | 0 | 0 | 1 |
| Q2 2021 | 73 | 0 | 0 | 0 | 1 |
| Q3 2021 | 16 | 42 | 11 | 7 | 6 |
| Q4 2021 | 51 | 52 | 10 | 9 | 2 |
| Q1 2022 | 23 | 39 | 36 | 21 | 6 |
| Q2 2022 | 28 | 43 | 33 | 21 | 4 |
| Q3 2022 | 21 | 63 | 27 | 12 | 16 |
| Q4 2022 | 21 | 63 | 29 | 16 | 13 |
| Q1 2023 | 12 | 37 | 17 | 8 | 21 |
Hedge funds changes in Recursion Pharmaceuticals stock options (Q1 2019 – Q1 2023)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 705,000 | 0 |
| Q3 2021 | 1,476,000 | 425,000 |
| Q4 2021 | 1,326,000 | 839,000 |
| Q1 2022 | 151,000 | 213,000 |
| Q2 2022 | 451,000 | 342,000 |
| Q3 2022 | 876,000 | 282,000 |
| Q4 2022 | 225,132 | 100,230 |
| Q1 2023 | 0 | 0 |